Lucidenic acid B TN1880
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Lucidenic acid B shows antioxidative, and anti-invasive effects, it inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Lucidenic acid B als
CAS nr:
95311-95-8
Purity:
98%
Molecular Weight:
474,59
SMILES:
C[C@H](CCC(O)=O)[C@@H](CC1=O)[C@@](C)([C@@H]2O)[C@]1(C)C([C@H](C[C@@H](C1(C)C)[C@]3(C)CCC1=O)O)=C3C2=O
Formula:
C27H38O7
Pathway:
Proteases/Proteasome,Apoptosis,DNA Damage/DNA Repair,Chromatin/Epigenetic,Apoptosis
Target:
Caspase,Caspase,PARP,PARP,BCL
